Generic Sibelium (Flunarizine)

Sibelium
Sibelium, containing Flunarizine, is a calcium channel blocker used for the prevention of migraine headaches and the management of vertigo, particularly that associated with Meniere's disease. It is intended for adults needing prophylactic migraine treatment. Our online pharmacy offers reliable access to Sibelium in 5mg and 10mg tablet strengths for your preventative health needs.
Select Package
5 mg
30 pills
Sibelium
£53.58
£ 42.42
£ 1.41 per pill
+ Package delivery insurance
+ Next orders 10% discount
Add to cart
save: £ 0.00
5 mg
60 pills
Sibelium
£61.62
£ 48.78
£ 0.81 per pill
+ Package delivery insurance
+ Next orders 10% discount
Add to cart
save: £ 36.17
5 mg
90 pills
Sibelium
£69.66
£ 55.15
£ 0.62 per pill
+ Package delivery insurance
+ Next orders 10% discount
Add to cart
save: £ 71.68
5 mg
120 pills
Sibelium
£78.59
£ 62.22
£ 0.51 per pill
+ Package delivery insurance
+ Next orders 10% discount
Add to cart
save: £ 108.08
5 mg
180 pills
Sibelium
£114.32
£ 90.50
£ 0.50 per pill
+ Package delivery insurance
+ Next orders 10% discount
Add to cart
save: £ 164.79
10 mg
30 pills
Sibelium
£57.16
£ 45.25
£ 1.50 per pill
+ Package delivery insurance
+ Next orders 10% discount
Add to cart
save: £ 0.00
10 mg
60 pills
Sibelium
£67.87
£ 53.73
£ 0.90 per pill
+ Package delivery insurance
+ Next orders 10% discount
Add to cart
save: £ 36.17
10 mg
90 pills
Sibelium
£82.17
£ 65.05
£ 0.72 per pill
+ Package delivery insurance
+ Next orders 10% discount
Add to cart
save: £ 70.34
10 mg
120 pills
Sibelium
£98.24
£ 77.77
£ 0.65 per pill
+ Package delivery insurance
+ Next orders 10% discount
Add to cart
save: £ 102.72
10 mg
180 pills
Sibelium
£136.65
£ 108.18
£ 0.60 per pill
+ Package delivery insurance
+ Next orders 10% discount
Add to cart
save: £ 162.11

Introduction

Sibelium is a oral tablet that contains the active compound flunarizine, a calcium-channel-blocking agent primarily used to prevent migraine attacks and to manage certain vertigo disorders. The medication is manufactured by Novartis (and other licensed producers) and is available in 5 mg and 10 mg tablets. While its main therapeutic role is migraine prophylaxis, flunarizine is also approved in many jurisdictions for the treatment of vestibular vertigo and for secondary prevention of episodic migraines. Clinicians occasionally prescribe it off-label for other neurological conditions, but such use is not authorized by the FDA, EMA or other major regulatory agencies.

What is Sibelium?

Sibelium is the brand name for tablets that contain the single active ingredient flunarizine. It belongs to the class of calcium-channel blockers that selectively inhibit the influx of calcium ions through L-type channels in neuronal and vascular smooth-muscle cells. The drug was first synthesized in the s and introduced to the market in the early s by Novartis.

Flunarizine is also marketed under other well-known brand names such as Mizoril and Ropinirol in various countries. Our online pharmacy provides this generic alternative as a cost-effective treatment option for patients who need migraine or vertigo prophylaxis.

How Sibelium Works

Flunarizine blocks L-type voltage-gated calcium channels, reducing calcium entry into presynaptic nerve terminals. This action dampens the release of excitatory neurotransmitters (e.g., glutamate, substance P) that are implicated in the initiation of migraine aura and headache pain. By stabilising neuronal membranes, the drug also diminishes the hypersensitivity of vestibular pathways that can lead to vertigo attacks.

Pharmacokinetic data show that peak plasma concentrations are reached 3-4 hours after oral ingestion, with a half-life of 18-20 hours, allowing once-daily dosing. The drug is extensively metabolised by hepatic CYP2C9 and CYP3A4 enzymes and excreted mainly in the feces.

Conditions Treated with Sibelium

Approved indication Rationale for effectiveness
Migraine prophylaxis (episodic migraine) By limiting calcium-mediated neurotransmitter release, flunarizine reduces the frequency and intensity of migraine attacks. Clinical trials in Europe have demonstrated a ≥50 % reduction in migraine days for many patients.
Vestibular vertigo (e.g., benign paroxysmal positional vertigo, Ménière’s disease) Calcium-channel blockade stabilises the vestibular hair-cell signaling, decreasing the likelihood of abnormal vertiginous episodes. Studies show improvement in balance scores and reduced need for rescue medication.
Secondary prevention of chronic migraine (in some EU member states) Long-term modulation of calcium influx helps to break the cycle of central sensitisation that characterises chronic migraine.

Off-Label and Investigational Uses of Sibelium

  • Restless-Leg Syndrome (RLS): Small open-label studies have reported symptom relief, likely owing to the drug’s dopaminergic-modulating properties. Formal approval is lacking.
  • Tension-type headache prophylaxis: Some clinicians use flunarizine for chronic tension-type headache, noting modest reductions in headache days, but evidence is limited to observational data.
  • Parkinsonian tremor control: Because flunarizine can influence dopaminergic pathways, case reports have explored its adjunctive use for tremor suppression; however, the risk of extrapyramidal side-effects cautions against routine use.

All off-label applications should be undertaken only under direct supervision of a qualified healthcare provider, as safety and efficacy have not been formally established by regulatory agencies.

Is Sibelium the Right Medication for You?

Sibelium is most suitable for adults who experience frequent migraine attacks (≥4 per month) or recurrent vertigo that is not adequately controlled by first-line therapies such as β-blockers, antiepileptics, or vestibular rehabilitation. The drug is particularly recommended when:

  • Patients have contraindications to other migraine preventives (e.g., asthma limiting β-blocker use).
  • A long-acting, once-daily prophylactic is preferred for adherence.
  • There is a documented positive response to calcium-channel blockade in prior trials.

Contraindications include known hypersensitivity to flunarizine, severe hepatic impairment, active depression or a history of depressive disorders, and Parkinsonian disease (due to potential exacerbation of motor symptoms). Pregnant or breastfeeding women should avoid Sibelium, as safety data are insufficient.

Risks, Side Effects, and Interactions

Common

  • Weight gain (usually modest, 1-3 kg).
  • Somnolence or fatigue - may affect driving or operating machinery.
  • Dry mouth - adequate hydration helps.
  • Dizziness - often transient during dose titration.

Rare

  • Extrapyramidal symptoms (parkinsonism, tremor).
  • Depressive mood changes - monitor patients with a history of depression.
  • Photosensitivity reactions - sun protection advised.

Serious

  • Severe depression or suicidal ideation - immediate medical attention required.
  • Hepatotoxicity (elevated transaminases); liver function should be checked before initiation and periodically thereafter.
  • Severe allergic reactions (angio-edema, anaphylaxis).

Drug-Drug Interactions

  • CYP3A4 inhibitors (e.g., ketoconazole, erythromycin) can increase flunarizine plasma levels → heightened risk of sedation and extrapyramidal effects.
  • Other central nervous system depressants (sedatives, antihistamines, alcohol) may potentiate drowsiness.
  • Concurrent calcium-channel blockers (verapamil, amlodipine) may have additive cardiovascular effects, though clinically significant interactions are rare.

Drug-Food Interactions

  • Grapefruit juice can inhibit CYP3A4 metabolism, potentially raising flunarizine concentrations.
  • High-fat meals do not markedly affect absorption, but taking the tablet with food can reduce gastrointestinal irritation.

Use: Dosing, Missed Dose, Overdose

  • Standard dosing: 5 mg once daily for initial prophylaxis; the dose may be increased to 10 mg once daily after 2-4 weeks if response is inadequate and tolerability is acceptable.
  • Administration: Swallow the tablet whole with a glass of water. It can be taken with or without food; however, consistent timing each day improves steady-state levels.
  • Missed dose: If a dose is forgotten and more than 12 hours have passed, skip the missed tablet and resume the regular schedule. Do not double-dose.
  • Overdose: Symptoms may include profound drowsiness, hypotension, and cardiac arrhythmias. Seek emergency medical care immediately; supportive measures such as activated charcoal and monitoring of cardiac function are standard.
  • Precautions: Avoid alcohol and other sedatives while taking Sibelium. Patients should refrain from operating heavy machinery until they know how the drug affects them.

FAQ

  • What is the typical time frame for migraine reduction after starting Sibelium? Patients often notice a decline in migraine frequency after 4-6 weeks of consistent daily dosing, although full therapeutic benefit may require up to 3 months.

  • Can I travel internationally with Sibelium tablets? Yes. Carry the medication in its original packaging with a pharmacist-issued label, and keep the quantity within personal use limits of the destination country.

  • Does flunarizine cause dependence or withdrawal symptoms? Flunarizine is not a controlled substance and does not produce physiological dependence. However, abrupt discontinuation may lead to rebound migraine attacks in some individuals; tapering the dose is advisable.

  • How does Sibelium differ from other migraine preventives like topiramate? Sibelium works by blocking calcium channels, whereas topiramate modulates voltage-gated sodium channels and enhances GABA activity. The side-effect profiles also differ, with Sibelium more likely to cause weight gain and somnolence.

  • Are there any special storage requirements for Sibelium tablets? Store at room temperature (15-30 °C), away from moisture and direct sunlight. Do not freeze the tablets.

  • Is Sibelium safe for elderly patients? Elderly individuals may be more susceptible to somnolence, dizziness, and extrapyramidal effects. Dose initiation at 5 mg with careful monitoring is recommended.

  • Can Sibelium be used in patients with hypertension? Flunarizine has minimal impact on systemic blood pressure, making it generally safe for hypertensive patients, but concurrent antihypertensive drugs should be reviewed for additive effects.

  • What inactive ingredients are present in the tablet? Typical excipients include lactose, microcrystalline cellulose, magnesium stearate, and silicon dioxide. Patients with severe lactose intolerance should consult a pharmacist.

  • Will taking Sibelium affect routine blood tests? Liver function tests (ALT, AST) may be modestly elevated; periodic monitoring is advised. The drug does not interfere with standard hematology panels.

  • How does flunarizine’s half-life influence dosing schedules? The long half-life (≈ 18 hours) supports once-daily dosing and provides relatively stable plasma concentrations, reducing the need for multiple daily doses.

Glossary

Calcium-Channel Blocker
A class of drugs that inhibit the flow of calcium ions through L-type channels, decreasing neuronal excitability and smooth-muscle contraction.
Prophylaxis
Preventive treatment intended to reduce the frequency or severity of future disease episodes.
Extrapyramidal Symptoms
Movement disorders (e.g., tremor, rigidity) caused by interference with dopamine pathways in the basal ganglia.
Half-Life
The time required for the plasma concentration of a drug to decrease by 50 %.

Buying Sibelium from Our Online Pharmacy

Sibelium can be purchased directly from our online pharmacy. By sourcing the medication through our service, patients benefit from:

  • Cost-effective pricing that approaches manufacturer-level rates, reducing out-of-pocket expense.
  • Verified quality, as all tablets are obtained from licensed, reputable suppliers who meet international pharmaceutical standards.
  • Discreet, reliable delivery - options include express shipping within 7 days for many regions, or regular airmail that typically arrives in 2-3 weeks.
  • Privacy-focused handling, with packaging that does not disclose the product name and secure payment channels that protect personal information.

Our pharmacy broker model works with overseas licensed pharmacies, enabling access to medications that may be unavailable or prohibitively expensive locally. Patients receive the medication safely, affordably, and with the confidentiality they expect.

Disclaimer

The information presented about Sibelium is intended for general educational purposes and does not substitute professional medical advice. Treatment choices, especially those involving off-label use, must be made under the guidance of a qualified healthcare professional. Readers are presumed to be competent adults capable of making informed health decisions. Our online pharmacy supplies Sibelium to individuals who may encounter limited availability through conventional pharmacies or who seek affordable generic options. Always discuss any medication changes with your clinician before initiating, modifying, or stopping therapy.

There is no review for this product at the moment, but you can be the first to add or you can read more in Testimonials Page about related products.
Package Example
Front View
Side View
Back View
Your order will be packed safe and secure and dispatched within 24 hours. This is exactly how your parcel will look like (pictures of a real shipping item). It has a size and a look of a regular private letter (9.4x4.3x0.3 inches or 24x11x0.7cm) and it does not disclose its contents
Shipping method Delivery time Price  
Delivery 14-21 days 10$ Tracking# available in 4 days
Delivery 9-14 days 30$ Tracking# available in 2 days
  • Shipping worldwide
  • Confidentiality and anonymity guarantee
  • Safe and secure
  • Discrete looking packages
  • Dispatch orders within 24 hours
  • 100% success delivery